These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36729669)

  • 21. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.
    Yurci A; Kalkan AO; Ozbakir O; Karaman A; Torun E; Kula M; Baskol M; Gursoy S; Yucesoy M; Bayram F
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1206-12. PubMed ID: 21971374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
    Pinzone MR; Moreno S; Cacopardo B; Nunnari G
    AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
    Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced bone density at completion of chemotherapy for a malignancy.
    Arikoski P; Komulainen J; Riikonen P; Jurvelin JS; Voutilainen R; Kröger H
    Arch Dis Child; 1999 Feb; 80(2):143-8. PubMed ID: 10325729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alendronate treatment in osteogenesis imperfecta.
    Madenci E; Yilmaz K; Yilmaz M; Coskun Y
    J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of alendronate in airways disease and low bone mineral density.
    Smith BJ; Laslett LL; Pile KD; Phillips PJ; Phillipov G; Evans SM; Esterman AJ; Berry JG
    Chron Respir Dis; 2004; 1(3):131-7. PubMed ID: 16281654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.
    Paggiosi MA; Peel N; McCloskey E; Walsh JS; Eastell R
    Osteoporos Int; 2014 Dec; 25(12):2729-41. PubMed ID: 25074351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.
    Ringe JD; Möller G
    Rheumatol Int; 2009 Dec; 30(2):213-21. PubMed ID: 19430791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term.
    Suzuki Y; Ishibashi Y; Omura N; Kawasaki N; Kashiwagi H; Yanaga K; Abo M; Urashima M
    J Gastrointest Surg; 2005; 9(7):955-60. PubMed ID: 16137591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of alendronic acid in the treatment of osteoporosis in children.
    Martín Siguero A; Áreas Del Águila VL; Franco Sereno MT; Fernández Marchante AI; Pérez Serrano R; Encinas Barrios C
    Farm Hosp; 2015 Nov; 39(6):350-4. PubMed ID: 26618379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.
    Omidvar B; Ghorbani A; Shahbazian H; Beladi Mousavi SS; Shariat Nabavi SJ; Alasti M
    Iran J Kidney Dis; 2011 Nov; 5(6):420-4. PubMed ID: 22057076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
    Ward LM; Rauch F; Whyte MP; D'Astous J; Gates PE; Grogan D; Lester EL; McCall RE; Pressly TA; Sanders JO; Smith PA; Steiner RD; Sullivan E; Tyerman G; Smith-Wright DL; Verbruggen N; Heyden N; Lombardi A; Glorieux FH
    J Clin Endocrinol Metab; 2011 Feb; 96(2):355-64. PubMed ID: 21106710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate calcium intake during long periods improves bone mineral density in healthy children. Data from the Childhood Obesity Project.
    Closa-Monasterolo R; Zaragoza-Jordana M; Ferré N; Luque V; Grote V; Koletzko B; Verduci E; Vecchi F; Escribano J;
    Clin Nutr; 2018 Jun; 37(3):890-896. PubMed ID: 28351509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermachine differences in DXA measurements vary by skeletal site, and impact the assessment of low bone density in children.
    Zemel BS; Wasserman H; Kelly A; Fan B; Shepherd J; Lappe J; Gilsanz V; Oberfield S; Winer KK; Kalkwarf HJ
    Bone; 2020 Dec; 141():115581. PubMed ID: 32795677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.
    Rajput S; Dutta A; Rajender S; Mithal A; Chattopadhyay N
    Front Endocrinol (Lausanne); 2023; 14():1098841. PubMed ID: 36817591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of whole body vibration (WBV) therapy on bone density and bone quality in osteopenic girls with adolescent idiopathic scoliosis: a randomized, controlled trial.
    Lam TP; Ng BK; Cheung LW; Lee KM; Qin L; Cheng JC
    Osteoporos Int; 2013 May; 24(5):1623-36. PubMed ID: 23011683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
    Emkey R; Delmas PD; Bolognese M; Borges JL; Cosman F; Ragi-Eis S; Recknor C; Zerbini CA; Neate C; Sedarati F; Epstein S
    Clin Ther; 2009 Apr; 31(4):751-61. PubMed ID: 19446148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.